Voyager Therapeutics (VT6) Q2 2026 Earnings Report
DE:VT6 Q2 2026 EPS Results
- Actual EPS
- -EUR 0.36
- Consensus EPS
- -EUR 0.43
- Beat/Miss
- Beat by +EUR 0.08
- One Year Ago EPS
- -EUR 0.51
DE:VT6 Q2 2026 Revenue Results
- Actual Revenue
- EUR 2.83M
- Expected Revenue
- EUR 4.04M
- Beat/Miss
- Missed by -EUR 1.21M
- YoY Revenue Growth
- -39.13%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/06/2026
- Time
- After Close
- Conference Call
- Thursday, August 6, 2026
DE:VT6 Upcoming Earnings
Voyager Therapeutics's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:VT6 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -0.37- | -0.42 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | -0.43-0.36 | -0.51 | 29.82% (+0.15) | |
| May 07, 2026 | 2026 (Q1) | -0.49-0.42 | -0.47 | 11.32% (+0.05) | |
| Mar 09, 2026 | 2025 (Q4) | -0.46-0.41 | -0.53 | 22.03% (+0.12) | |
| Nov 10, 2025 | 2025 (Q3) | -0.47-0.42 | -0.14 | -193.75% (-0.28) | |
| Aug 06, 2025 | 2025 (Q2) | -0.47-0.51 | -0.16 | -216.67% (-0.35) | |
| May 06, 2025 | 2025 (Q1) | -0.40-0.47 | -0.18 | -165.00% (-0.30) | |
| Mar 11, 2025 | 2024 (Q4) | -0.33-0.53 | 1.12 | -147.20% (-1.65) | |
| Nov 12, 2024 | 2024 (Q3) | -0.40-0.14 | -0.53 | 72.88% (+0.38) | |
| Aug 06, 2024 | 2024 (Q2) | -0.37-0.16 | -0.46 | 64.71% (+0.30) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
